Status:

ACTIVE_NOT_RECRUITING

Phase II Laser Focal Therapy of Prostate Cancer

Lead Sponsor:

HALO Diagnostics

Conditions:

Prostate Cancer

Eligibility:

MALE

45-90 years

Brief Summary

Target recruitment: 1000 subjects. The purpose of this research study is to continue to investigate the safety and effectiveness of using MR (magnetic resonance) guided laser focal therapy for prostat...

Detailed Description

Laser-induced interstitial thermal therapy (LITT) is a novel form of controlled, targeted thermal ablation that may offer measurable advantages over other ablative therapies for focal prostate therapy...

Eligibility Criteria

Inclusion

  • Treatment Naïve patients:
  • Male, 45 years of age or older.
  • Diagnosis of prostate adenocarcinoma.
  • Clinical stage T1c or T2a.
  • Gleason score of 7 (3+4 or 4+3) or less.
  • Three or fewer biopsy cores with prostate cancer.
  • PSA density not exceeding 0.375.
  • One, two, or three tumor suspicious regions identified on multiparametric MRI.
  • Negative radiographic indication of extra-capsular extent.
  • Karnofsky performance status of at least 70.
  • Estimated survival of 5 years or greater, as determined by treating physician.
  • Tolerance for anesthesia/sedation.
  • Ability to give informed consent.
  • At least 6 weeks since any previous prostate biopsy.
  • MR-guided biopsy confirmation of one or more MRI-visible prostate lesion(s) with Gleason score of 7 (3+4 or 4+3) or less.
  • Salvage candidates will be accepted upon physician referral.

Exclusion

  • Presence of any condition (e.g., metal implant, shrapnel) not compatible with MRI.
  • Severe lower urinary tract symptoms as measured by an International Prostate Symptom Score (IPSS) of 20 or greater
  • History of other primary non-skin malignancy within previous three years.
  • Diabetes
  • Smoker

Key Trial Info

Start Date :

May 1 2016

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

November 1 2036

Estimated Enrollment :

1000 Patients enrolled

Trial Details

Trial ID

NCT02243033

Start Date

May 1 2016

End Date

November 1 2036

Last Update

March 25 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Desert Medical Imaging

Indian Wells, California, United States, 92210